C07D 263/22
With only hydrogen atoms or radicals containing only hydrogen and carbon atoms
Official title: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
C07D263/22 (With only hydrogen atoms or radicals containing only hydrogen and carbon atoms) appears on 256 US grants and 196 published applications in this corpus.
Search patents in C07D- Granted patents
- 256
- Published applications
- 196
- Assignees
- 167
- Inventors
- 964
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 5 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 5 | 0 |
| 1990 | 2 | 0 |
| 1991 | 7 | 0 |
| 1992 | 8 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 9 | 0 |
| 1998 | 10 | 0 |
| 1999 | 3 | 0 |
| 2000 | 8 | 0 |
| 2001 | 15 | 1 |
| 2002 | 7 | 7 |
| 2003 | 4 | 6 |
| 2004 | 5 | 13 |
| 2005 | 3 | 11 |
| 2006 | 10 | 9 |
| 2007 | 10 | 10 |
| 2008 | 7 | 7 |
| 2009 | 1 | 10 |
| 2010 | 5 | 13 |
| 2011 | 6 | 10 |
| 2012 | 5 | 6 |
| 2013 | 7 | 7 |
| 2014 | 8 | 9 |
| 2015 | 5 | 10 |
| 2016 | 14 | 11 |
| 2017 | 8 | 7 |
| 2018 | 3 | 0 |
| 2019 | 1 | 5 |
| 2020 | 5 | 8 |
| 2021 | 3 | 5 |
| 2022 | 7 | 3 |
| 2023 | 4 | 9 |
| 2024 | 5 | 10 |
| 2025 | 7 | 6 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Low toxicity NMP substitutes and uses thereof25 Aug 2026US 12,715,850 B2Advancion Corporation
- Hepatitis B antiviral agents16 Dec 2025US 12,496,282 B2Enanta Pharmaceuticals, Inc.
- Benzothiophene derivative regulator, preparation method therefor and use thereof4 Nov 2025US 12,459,931 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Azide-functionalized copolymers4 Nov 2025US 12,460,049 B2Susos AG
- Triazole compounds and preparation method therefor and use thereof5 Aug 2025US 12,378,204 B2Wuhan Ll Science and Technology Development Co., Ltd.
- Process for preparing an n-substituted-2-oxazolidinone23 Jul 2026US 2026/0209192 A1Huntsman Petrochemical Corporation
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
- Intermediate salt for the preparation of bis(fluoroalkyl) benzodiazepinone compounds29 Jan 2026US 2026/0028319 A1Immunome, Inc.
- Alpha, beta-unsaturated amide compound, and preparation method therefor, and pharmaceutical composition and use thereof9 Oct 2025US 2025/0313539 A1Kunming Institute of Zoology, Chinese Academy of Sciences
- Rxfp1 agonists28 Aug 2025US 2025/0268903 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- GABA and L-glutamic acid analogs for antiseizure treatment88US 5,563,175 ANorthwestern University · 1996
- Retroviral protease inhibiting compounds86US 5,914,332 AAbbott Laboratories · 1999
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds78US 6,759,554 B2Massachusetts Institute of Technology · 2004
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds72US 6,867,298 B2Massachusetts Institute of Technology · 2005
- Process for the synthesis of azetidinones68US 6,207,822 B1Schering Corporation · 2001